-
November 9, 2021
-
Haemonetics Announces CFO William P. Burke's Retirement for June 2022
View details
-
November 9, 2021
-
Haemonetics 2nd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website
View details
-
October 6, 2021
-
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2022 Results: November 9, 2021
View details
-
September 30, 2021
-
Haemonetics Announces VASCADE MVP® Venous Vascular Closure System Gains the First and Only FDA Approval for Same-Day Discharge Following Atrial Fibrillation Ablation
View details
-
August 25, 2021
-
Haemonetics To Present At The 19th Annual Morgan Stanley Global Healthcare Conference
View details
-
August 11, 2021
-
Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website
View details
-
August 9, 2021
-
Lloyd E. Johnson Joins Haemonetics' Board of Directors; Ellen Zane Announced as New Board Chair
View details
-
July 9, 2021
-
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2022 Results: August 11, 2021
View details
-
May 13, 2021
-
Haemonetics 4th Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website
View details
-
April 29, 2021
-
Peer-Reviewed Results of Haemonetics' Improving Plasma Collection (IMPACT) Trial Published in the Journal TRANSFUSION
View details
-
April 23, 2021
-
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2021 Results: May 13, 2021
View details
-
April 19, 2021
-
Haemonetics Provides Update On U.S. Plasma Business
View details
-
March 2, 2021
-
Haemonetics Prices $435.0 Million Convertible Senior Notes Offering
View details
-
March 1, 2021
-
Haemonetics Announces Proposed Convertible Senior Notes Offering
View details
-
February 26, 2021
-
Haemonetics To Present At The Jefferies Plasma Summit
View details
-
February 2, 2021
-
Haemonetics 3rd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website
View details
-
January 22, 2021
-
Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic
View details
-
January 20, 2021
-
Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio
View details
-
January 5, 2021
-
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2021 Results: February 2, 2021
View details